Shenzhen Hepalink Pharmaceutical Group Co., Ltd. announced Poll Results of the 2022 Annual General Meeting Held on May 22, 2023 and approved appointment of Mr. Huang Peng as an independent non-executive Director of the Company and appointment of Mr. Yi Ming as an independent non-executive Director of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.67 CNY | +0.52% | -2.81% | -17.56% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.56% | 1.76B | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Directorate Changes